Infusion Consumables was Icu Medical’s largest product and service line in fiscal 2025, bringing in $1.11B of $2.23B (50%).
| Product and Service | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infusion Consumables | $974.99M | $969.13M | $1.04B | $1.11B | ||||||||||||
| Vital Care | $687.57M | $660.95M | $690.77M | $437.92M | ||||||||||||
| Infusion Systems | $617.44M | $629.04M | $652.41M | $684.21M | ||||||||||||
| Iv Solutions | — | — | — | — | ||||||||||||
| Infusion Therapy | — | — | — | — | ||||||||||||
| Infusion Therapy Revenue | — | — | — | — | ||||||||||||
| Critical Care Revenue | — | — | — | — | ||||||||||||
| Critical Care | — | — | — | — | ||||||||||||
| Oncology Revenue | — | — | — | — | ||||||||||||
| Other Revenue | — | — | — | — | ||||||||||||
| Total | $2.28B | $2.26B | $2.38B | $2.23B |
Icu Medical brought in $2.23B from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 6.3% from $2.38B in fiscal 2024. Infusion Consumables was the largest at $1.11B (49.7%), ahead of Infusion Systems at $684.21M (30.7%) and Vital Care at $437.92M (19.6%).
Compared with fiscal 2024, Infusion Consumables grew fastest, up 6.8% to $1.11B, while Vital Care fell the most, down 36.6% to $437.92M. From fiscal 2022 to 2025, combined revenue from these lines fell from $2.28B to $2.23B, a compound annual decline of 0.7%. Infusion Consumables' share of the total rose from 42.8% to 49.7%.
United States was Icu Medical’s largest region in fiscal 2025, bringing in $1.36B of $2.23B (61%).
| Geography | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.46B | $1.44B | $1.53B | $1.36B | |||||||
| Emea | $367.41M | $373.57M | $393.53M | $411.68M | |||||||
| Apac [Domain] | $257.21M | $241.70M | $232.82M | $232.90M | |||||||
| Other Foreign Countries | $195.31M | $203.84M | $223.59M | $230.56M | |||||||
| Europe | — | — | — | — | |||||||
| Other Latam | — | — | — | — | |||||||
| Canada | — | — | — | — | |||||||
| Asia Pacific | — | — | — | — | |||||||
| Total | $2.28B | $2.26B | $2.38B | $2.23B |
Icu Medical brought in $2.23B from its four regions in fiscal 2025, the year ended December 31, 2025. That was down 6.3% from $2.38B in fiscal 2024. United States was the largest at $1.36B (60.8%), ahead of Emea at $411.68M (18.5%) and Apac [Domain] at $232.90M (10.4%). The remaining region, Other Foreign Countries, brought in $230.56M.
Compared with fiscal 2024, Emea grew fastest, up 4.6% to $411.68M, while United States fell the most, down 11.5% to $1.36B. From fiscal 2022 to 2025, combined revenue from these regions fell from $2.28B to $2.23B, a compound annual decline of 0.7%. United States' share of the total fell from 64.0% to 60.8%.
Icu Medical (ICUI) reports its revenue by product and service and by geography. In fiscal 2025, Infusion Consumables was its largest product and service line, bringing in $1.11B (49.7% of the total), followed by Infusion Systems at $684.21M (30.7%).
Infusion Consumables was Icu Medical's largest product and service line in fiscal 2025, bringing in $1.11B, or 49.7% of the $2.23B total across its three product and service lines.
United States was Icu Medical's largest region in fiscal 2025, bringing in $1.36B, or 60.8% of the $2.23B total across its four regions.
Among Icu Medical's product and service lines that make up at least 2% of revenue, Infusion Consumables grew fastest in fiscal 2025, up 6.8% from $1.04B to $1.11B.
Every figure comes from Icu Medical's annual financial filings, as reported. Each line keeps the name Icu Medical gives it, and years follow its fiscal calendar.
Icu Medical's revenue by product and service goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.